Supply Chain

Hospitals and health systems cannot effectively quantify and control costs without first targeting key expense areas. However, administrators inundated with cost responsibilities regularly overlook major savings opportunities.

Here are four drugs or medical devices that have been approved by the FDA since Sept. 14:

The Food and Drug Administration issued a warning letter to Pharmaceutical Laboratories and Consultants referencing several violations at the Addison, Ill.-based lab, including the presence of a microbrewery in its drug testing area.

Accenture and Merck are building an informatics research platform on Amazon's cloud computing service Amazon Web Services to support data-driven drug development.

Caregivers and healthcare providers deliver compassionate, quality healthcare to patients in need, while also focusing on improving the overall health of individuals and communities. In recent years, the healthcare industry has evolved to include more policies pertaining to EHRs, meaningful…

Aurora, Colo.-based UCHealth issued an urgent call for blood donations after several severe trauma incidents drained supplies at the health system's Fort Collins, Colo.-based Poudre Valley Hospital and Loveland, Colo.-based Medical Center of the Rockies, according to the Coloradoan.

As hospitals and health systems look for every opportunity to save, the supply chain is a growing focus and product pricing is a natural target. But beyond these hard costs, there are other savings opportunities that are often overlooked.

Here are three notable drugs or medical devices that have been approved by the FDA since Sept. 7:

Apple Watch Series 4 includes an electrocardiogram sensor to alert users if their heart rhythm is irregular, Apple COO Jeff Williams said during the company's Sept. 12 event in Cupertino, Calif.

The first step in reducing costs is identifying areas of expense, but with abundant costs to account for, it's easy for hospital leaders to overlook some supply chain expenses.